Peroral route: an opportunity for protein and peptide drug delivery.
about
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesBacterial-Derived Polymer Poly-γ-Glutamic Acid (γ-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical ApplicationsDrug delivery systems, CNS protection, and the blood brain barrierPolymeric nanoparticle technologies for oral drug delivery.Protein and peptide parenteral controlled delivery.Strategies to improve oral drug bioavailability.Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.Polymeric nanoparticle drug delivery technologies for oral delivery applications.Approaches for enhancing oral bioavailability of peptides and proteinsProtein and Peptide drug delivery: oral approaches.Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.Synthesis of silica vesicles with controlled entrance size for high loading, sustained release, and cellular delivery of therapeutical proteins.Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery.Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).The MPEG monophosphate ester: synthesis and characterization.Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate.Controlled delivery of bovine serum albumin from carboxymethyl xanthan microparticles.Antibiotic gold: tethering of antimicrobial peptides to gold nanoparticles maintains conformational flexibility of peptides and improves trypsin susceptibility.Oral insulin delivery: existing barriers and current counter-strategies.Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.Responsive Polymer-Inorganic Hybrid Nanogels for Optical Sensing, Imaging, and Drug DeliveryPrerequisite Characteristics of Nanocarriers Favoring Oral Insulin Delivery: Nanogels as an OpportunitySilica-based multifunctional nanodelivery systems toward regenerative medicineEmerging functional nanomaterials for therapeutics
P2860
Q26744008-9740C930-E61B-4082-A853-DB4FE5AE7659Q29248031-F4628705-428E-4D8A-A0F2-89510B6DCC62Q30432845-07175F87-D72C-4C62-97FF-8A3203B87CBEQ34225096-31DA89CE-5BB7-4B4B-9423-9072EFA82F95Q35842593-195B6A5F-C16D-4957-8617-8F07FF405986Q36316751-55E94F41-5DB5-4B2C-A2C7-968D44064CA7Q36500104-C8D620EA-A4D1-4DDD-BA6E-D4478605C9D2Q36808308-DBC198C5-3937-4BA1-868F-023516AA261EQ36922557-4013D90C-6073-493D-A5F1-FCD3539667FAQ37666699-CF65CDD8-74E6-4CBB-923B-48FA6FF50E21Q37989408-B4AEC58C-A4C7-4316-9043-C7EDDD233D4AQ38195730-CC59B5EB-2A8F-4D2B-9DDC-DF6C5FC867C0Q38401892-86A85808-EB6E-4F65-9E76-9686AC451C73Q38757836-B6D4E8D9-D4E4-444A-9995-7A335B199834Q38971966-4BC847F2-21B0-4923-AEC2-584D6B4743F0Q39369529-13BD8AD6-08E8-4562-B41D-B3099ACEA70FQ40728949-BAA4CFBF-8B29-445C-ACAD-BD917DB2A3B1Q43252566-D5E89978-E208-47E2-A24B-1A2D7BC83BFBQ45105442-59D9F662-A20A-42F6-85E0-41A6DF200755Q45948385-4A8785A9-059C-497A-9675-255A77E94B74Q48147426-E609ECAA-F3B0-49C2-8193-566EA1380C03Q48203947-0030319F-99DB-418A-8B61-93CDA5914C58Q50891271-F5CC7E37-0BC0-4F9E-A987-CE0DDB9A64A7Q57341111-6E25E536-67B8-40C4-BCE6-952A067C9A1BQ57348419-E5E40B01-0A4F-48F4-B7E0-78A35703102DQ57367659-EC55D5C1-3DA3-4149-B0B1-2B0533A8C113Q57376444-2BCC7ED0-A5F2-42C1-AA09-79AD6FA26283
P2860
Peroral route: an opportunity for protein and peptide drug delivery.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Peroral route: an opportunity for protein and peptide drug delivery.
@ast
Peroral route: an opportunity for protein and peptide drug delivery.
@en
Peroral route: an opportunity for protein and peptide drug delivery.
@nl
type
label
Peroral route: an opportunity for protein and peptide drug delivery.
@ast
Peroral route: an opportunity for protein and peptide drug delivery.
@en
Peroral route: an opportunity for protein and peptide drug delivery.
@nl
prefLabel
Peroral route: an opportunity for protein and peptide drug delivery.
@ast
Peroral route: an opportunity for protein and peptide drug delivery.
@en
Peroral route: an opportunity for protein and peptide drug delivery.
@nl
P356
P1433
P1476
Peroral route: an opportunity for protein and peptide drug delivery.
@en
P2093
P304
P356
10.1021/CR000700M
P577
2001-11-01T00:00:00Z